Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Probiotics: insights and new opportunities for Clostridioides difficile intervention

15 May 2022

Abstract excerpt

. Despite the availability of antimicrobial drugs to treat CDI, such as vancomycin, metronidazole, and fidaxomicin, recurrence of infection remains a significant clinical challenge. The use of live commensal microorganisms, or probiotics, is one of the most investigated non-antibiotic therapeutic options to balance gastrointestinal (GI) microbiota and subsequently tackle dysbiosis. In this review, we will discuss...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35574602
DOI: 10.1080/1040841x.2022.2072705

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Probiotics: insights and new opportunities for Clostridioides difficile interventionPMID 35574602Read ↗

Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection PreventionSemantic proximity Read ↗

The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by Clostridioides difficileSemantic proximity Read ↗

Antibiotic Treatments for Clostridium difficile Infection Are Associated with Distinct Bacterial and Fungal Community StructuresSemantic proximity Read ↗

Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carriage and non-CDI diarrheaSemantic proximity Read ↗

Structural and functional changes in the gut microbiota associated to Clostridium difficile infectionSemantic proximity Read ↗

Gut microbiota and Clostridium difficile infectionsSemantic proximity Read ↗

Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial ApplicationsSemantic proximity Read ↗

Non-invasive treatment of Clostridioides difficile infection with a human-origin probiotic cocktail through gut microbiome-gut metabolome modulationsSemantic proximity Read ↗

Slow and incomplete recovery of gut microbiome in Clostridioides difficile patients treated with metronidazoleSemantic proximity Read ↗

Microbial interactions and the homeostasis of the gut microbiome: the role of BifidobacteriumSemantic proximity Read ↗

Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factorsSemantic proximity Read ↗

Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.